The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Open accessAbstract
Objective: To update evidence‐based recommendations for the treatment of patients with ankylosing spondylitis ( AS ) and nonradiographic axial spondyloarthritis (SpA). Methods: We conducted updated systematic literature reviews for 20 clinical questions on pharmacologic treatment addressed in the 2015 guidelines, and for 26 new questions on pharmacologic treatment, treat‐to‐target strategy, and use of imaging. New questions addressed the use of secukinumab, ixekizumab, tofacitinib, tumor necrosis factor inhibitor ( TNF i) biosimilars, and biologic tapering/discontinuation, among others. We used the Grading of Recommendations, Assessment, Development and Evaluation methodology to assess the quality of evidence and formulate recommendations and required at least 70% agreement among the voting panel. Results: Recommendations for AS and nonradiographic axial SpA are similar. TNF i are recommended over secukinumab or ixekizumab as the first biologic to be used. Secukinumab or ixekizumab is recommended over the use of a second TNF i in patients with primary nonresponse to the first TNF i. TNF i, secukinumab, and ixekizumab are favored over tofacitinib. Co‐administration of low‐dose methotrexate with TNF i is not recommended, nor is a strict treat‐to‐target strategy or discontinuation or tapering of biologics in patients with stable disease. Sulfasalazine is recommended only for persistent peripheral arthritis when TNF i are contraindicated. For patients with unclear disease activity, spine or pelvis magnetic resonance imaging could aid assessment. Routine monitoring of radiographic changes with serial spine radiographs is not recommended. Conclusion: These recommendations provide updated guidance regarding use of new medications and imaging of the axial skeleton in the management of AS and nonradiographic axial SpA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Evaluation of Diagnostic Criteria for Ankylosing Spondylitis
Linden, S. V. D., Valkenburg, H. A., & Cats, A. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270401 · Cited by 5,697
Rudwaleit, M., van der Heijde, D., Landewé, R., Listing, J., Akkoc, N., Brandt, J., Braun, J., Chou, C. T., Collantes-Estevez, E., Dougados, M., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.108233 · Cited by 3,690
Self-citationKornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Going from evidence to recommendations
Guyatt, G. H., Oxman, A. D., Kunz, R., Falck-Ytter, Y., Vist, G. E., Liberati, A., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39493.646875.ae · Cited by 1,810
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Su, C., Sands, B. E., D’Haens, G. R., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606910 · Cited by 1,770
Self-citationHueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Lichtenstein, G. R., Loftus, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B., & Sands, B. E. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2018.27 · Cited by 1,421
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Baeten, D., Sieper, J., Braun, J., Baraliakos, X., Dougados, M., Emery, P., Deodhar, A., Porter, B., Martin, R., Andersson, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505066 · Cited by 1,029
Self-citationAnkylosing Spondylitis and Axial Spondyloarthritis
Taurog, J. D., Chhabra, A., & Colbert, R. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1406182 · Cited by 900
Park, W., Hrycaj, P., Jeka, S., Kovalenko, V., Lysenko, G., Miranda, P., Mikazane, H., Gutierrez-Ureña, S., Lim, M., Lee, Y.-A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203091 · Cited by 606
Ward, M. M., Deodhar, A., Akl, E. A., Lui, A., Ermann, J., Gensler, L. S., Smith, J. A., Borenstein, D., Hiratzka, J., Weiss, P. F., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39298 · Cited by 548
Self-citationvan der Heijde, D., Deodhar, A., Wei, J. C., Drescher, E., Fleishaker, D., Hendrikx, T., Li, D., Menon, S., & Kanik, K. S. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210322 · Cited by 376
Self-citationvan der Heijde, D., Cheng-Chung Wei, J., Dougados, M., Mease, P., Deodhar, A., Maksymowych, W. P., Van den Bosch, F., Sieper, J., Tomita, T., Landewé, R., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31946-9 · Cited by 370
Self-citationDick, A. D., Tugal-Tutkun, I., Foster, S., Zierhut, M., Melissa Liew, S. H., Bezlyak, V., & Androudi, S. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.040 · Cited by 365
Rudwaleit, M., Rødevand, E., Holck, P., Vanhoof, J., Kron, M., Kary, S., & Kupper, H. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092585 · Cited by 297
Song, I.-H., Hermann, K., Haibel, H., Althoff, C., Listing, J., Burmester, G., Krause, A., Bohl-Bühler, M., Freundlich, B., Rudwaleit, M., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.139667 · Cited by 285
Heiberg, M. S., Koldingsnes, W., Mikkelsen, K., Rødevand, E., Kaufmann, C., Mowinckel, P., & Kvien, T. K. (2008) · Arthritis Care & Research · doi:10.1002/art.23333 · Cited by 256
Souto, A., Maneiro, J. R., & Gómez-Reino, J. J. (2015) · Rheumatology · doi:10.1093/rheumatology/kev374 · Cited by 180
Souto, A., Maneiro, J. R., Salgado, E., Carmona, L., & Gómez-Reino, J. J. (2014) · Lara D. Veeken · doi:10.1093/rheumatology/keu172 · Cited by 155
Lie, E., Lindström, U., Zverkova-Sandström, T., Olsen, I. C., Forsblad‐d’Elia, H., Askling, J., Kapetanovic, M. C., Kristensen, L. E., & Jacobsson, L. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210931 · Cited by 130
Reich, K., Leonardi, C. L., Langley, R. G. B., Warren, R. B., Bachelez, H., Romiti, R., Ohtsuki, M., Xu, W., Acharya, N. V., Solotkin, K. C., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.10.027 · Cited by 99
Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients
Calvo-Río, V., Blanco, R., Santos-Gómez, M., Rubio‐Romero, E., Cordero‐Coma, M., Flores, A. G., Veroz, R., Torre, I., Hernández, F. F., Atanes, A., et al. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.03.002 · Cited by 96
Yun, H., Xie, F., Delzell, E., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204011 · Cited by 93
Is methotrexate effective in ankylosing spondylitis?
Roychowdhury, B. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.11.1330 · Cited by 89
Targan, S. R., Feagan, B. G., Vermeire, S., Panaccione, R., MELMED, G. Y., Blosch, C. M., Newmark, R., Zhang, N., Chon, Y., Lin, S., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.084 · Cited by 88
Clinical investigation of methotrexate in the treatment of ankylosing spondylitis
Altan, Ü. B. L. (2001) · Scandinavian Journal of Rheumatology · doi:10.1080/030097401753180318 · Cited by 83
Atar, D., Birkeland, K., & Uhlig, T. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.128462 · Cited by 74
Ward, M. M., Deodhar, A. A., Akl, E. A., Lui, A., Ermann, J., Gensler, L. S., Smith, J. A., BORENSTEIN, D. G., Hiratzka, J. R., Weiss, P. F., et al. (2015) · Arthritis Care & Research · doi:10.1002/acr.22708 · Cited by 65
Self-citationDougados, M., Wood, E. A., Combe, B. G., Schaeverbeke, T., Miceli‐Richard, C., Berenbaum, F., Koppiker, N., Dubanchet, A., & Logeart, I. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0481-5 · Cited by 44
Wang, R., Dasgupta, A., & Ward, M. M. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.170224 · Cited by 25
Self-citation
Cited by
van der Heijde, D., Song, I.-H., Pangan, A. L., Deodhar, A., van den Bosch, F., Maksymowych, W. P., Kim, T.-H., Kishimoto, M., Everding, A., Sui, Y., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32534-6 · Cited by 357
Self-citationDeodhar, A., Sliwinska-Stanczyk, P., Xu, H., Baraliakos, X., Gensler, L. S., Fleishaker, D., Wang, L., Wu, J., Menon, S., Wang, C., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219601 · Cited by 259
Self-citation
Metadata
- Authors
- Ward, M. M., Deodhar, A., Gensler, L. S., Dubreuil, M., Yu, D., Khan, M. A., Haroon, N., Borenstein, D., Wang, R., Biehl, A., Fang, M. A., Louie, G., Majithia, V., Ng, B., Bigham, R., Pianin, M., Shah, A. A., Sullivan, N., Turgunbaev, M., Oristaglio, J., Turner, A., Maksymowych, W. P., & Caplan, L.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2019-08-21
- Volume
- 71
- Issue
- 10
- Pages
- 1285-1299
- ISSN
- 0893-7524 (ISSN-L)
- 2151-464X
- 2151-4658
- OpenAlex
- W2969598066
- Cited by
- 693
- References
- 33
- FWCI
- 53.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.